Skip to content
Open access

Inflammatory signaling drives SQSTM1-dependent suppression of interferon-γ–induced MHC class I surface expression

Oct 2026 · bioRxiv · 0 citations · 20 references
Biology

TL;DR

Findings identify post-translational MHC-I trafficking as a previously underappreciated regulatory layer linking inflammatory signaling to the canonical IFN-γ–MHC-I axis and reveal an SQSTM1-dependent mechanism controlling MHC-I surface availability under immune-inflamed tumor conditions.

Read PDF

Similar papers

Oct 2026

4-Octyl itaconate suppresses IFN-γ-induced MHC II expression in bone marrow-derived macrophages.

Macrophages function as professional antigen-presenting cells that integrate inflammatory signals with metabolic reprogramming to shape immune responses. Itaconate, an immunometabolite derived from ACOD1/IRG1 activity in activated macrophages, has been implicated in the regulation of inflammatory responses, yet its rol...

Zhi-Ying Zhou, Yi-Xiu Ni, Shan-Shan Huang et al. · 0 citations
Open access 2026

Role of SLC25A39 in IFNγ-induced MHC-I Expression in a Pancreatic Cancer Cell Model

Immunotherapy has revolutionized cancer treatment. One of the key mediators of tumor-immune interactions is the major histocompatibility complex (MHC) class I (MHC-I), a protein expressed on the surface of cancer cells to present tumor-derived antigens to CD8+ T cells, and loss or downregulation of MHC-I contributes to...

Max Chi · 0 citations
Review Open access Sep 2026

Tumor-intrinsic execution of interferon-γ-associated immunity in bladder cancer: checkpoints in signaling, recruitment, and recognition

This Mini Review examines tumor-intrinsic IFN-γ-associated immunity at three functional checkpoints: proximal IFN-γ sensing and signal transduction, chemokine-mediated effector-cell recruitment, and antigen-presentation-dependent tumor recognition.

Jing-Jing Lu, Yi-Chun Jiang, Yan-Shan Jin et al. · 0 citations
Open access Oct 2026

MicroRNA Expression in Macrophages Regulates Antibody-Dependent Effector Function and B-cell Lymphoma Therapy

Abstract CD163+ tumor-associated macrophages (TAM) are associated with poor response to immunochemotherapy in patients with diffuse large B-cell lymphoma and comprise a significant proportion of the tumor microenvironment (TME). Targeting these TAMs to reverse immunosuppression is an attractive approach for improving t...

J. Longley, L. Dahal, Russell B. Foxall et al. · 0 citations
Open access Oct 2026

Type I IFN promotes ILC2-to-ILC1 plasticity in pre-clinical radiation-induced lung injury

Radiation-induced lung injury (RILI) is a common dose-limiting toxicity after radiotherapy for lung cancer, but the immunological mechanisms contributing to RILI pathogenesis remain poorly understood. Here we analyze a RILI mouse model using high-dose, restricted-field irradiation to the left lung. Flow cytometry and c...

Jaeho Kim, Hai-Qing Li, R. Mannan et al. · 0 citations
Open access Sep 2026

IFNγ-dependent tumor-cell MHC-II is restrained by MAPK signaling and associated with immunotherapy responsiveness in pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is characterized by an immunosuppressive tumor microenvironment (TME) and poor prognosis. Although major histocompatibility complex class II (MHC-II) is typically expressed by professional antigen-presenting cells, its regulation and significance in malignant PDAC cells remain un...

Can-Ping Chen, Yi Zhang, Xi Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.